ScholarWorks@Gachon: Nguyen, Thi Thao Linh

Detailed Information

Nguyen, Thi Thao Linh (NGUYEN THI THAO LINH)

Pharmacy (Dept.of Pharmacy)

Research Area

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Pharmacokinetics:5||Surface functionalization:3||pharmacokinetics:3||Ondansetron hydrochloride:3||Mesoporous silica nanoparticles:2||Spray drying:2||Cancer therapy:2||Sustainedrelease:2||Inorganic nanoparticles:2||20(S)protopanaxadiol:2||Validation:2||Parenteral formulation:2||LCMS:2||Nanostructured lipid carriers:2||Gold nanoparticles:2||validation:2||Entrapment efficiency:2||nosetobrain:2||Drug delivery applications:2||MS:2||drug delivery:2||HPLC–MS/MS:1||Homogenization:1||KD025:1||LCMS/MS:1||Lipid nanoparticles:1||Liquid lipid:1||Methylcellulose:1||Microparticles:1||NLCs:1||Nanoparticles:1||OCT2:1||OCTN1 substrate:1||OCTN2:1||Oil suspension:1||Oral bioavailability:1||Organic phase:1||Pgp:1||PLGA:1||Particle size:1||Pharmacokinetic:1||Polydispersity index:1||SGK1 inhibitor:1||SLNs:1||Selfnanoemulsifying drug delivery system:1||Solid lipid:1||Solvent injection:1||Sustained release:1||Targeted delivery:1||Type 2 diabetes:1||antibody:1||biodistribution:1||bioavailability:1||biphenyl:1||bloodbrain barrier:1||brain:1||brain targeting:1||central nervous system:1||dissolution:1||emulsions:1||entrapment efficiency:1||extensive glucuronidation metabolism:1||glucagon receptor antagonist:1||immune:1||inhibitors:1||intranasal:1||liposome:1||liposomes:1||lung tissue:1||micelles:1||microemulsion:1||nanostructured lipid carriers:1||olaparib:1||ondansetron hydrochloride:1||oral absorption:1||permeability:1||pharmacodynamics:1||pharmacokinetic:1||phospholipid:1||polymeric nanoparticles:1||proteolysistargeting chimera:1||selfmicroemulsifying drug delivery system:1||sirolimus:1||solid lipid nanoparticles:1||solubility:1||solvent injection:1||stability:1||sulfonamide:1||systemic:1||vaccine:1||1 alpha,25dihydroxyvitamin D3:1||whole blood:1||1α,25Dihydroxyvitamin D3:1||ARV110:1||Aqueous phase:1||Bioanalytical method:1||Biodegradation:1||Biodistribution:1||Cold highpressure homogenization:1||Comprehensive ternary phase diagram:1||Controlled release:1||Cytochrome P450 (CYP):1||Diffusion:1||Drug interactions:1||Drug metabolism:1||Drugdrug interactions:1||Emulsifier:1||Endogenous biomarkers:1||Ergothioneine:1||GSK650394:1||Ginsenoside:1||Granisetron hydrochloride:1||

RSS_1.0 RSS_2.0 ATOM_1.0

1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE